Company: NREF
Filing Date: 2025-04-02
Form Type: DEF 14A
Source: 0001437749-25-010694
Chunk: 65

Company: NexPoint Real Estate Finance, Inc.
Filing Date: 2025-04-02
Form: DEF 14A
Chunk 65
---
 trust described above and 19,511 shares are held by Drugcrafters, L.P., for which Mr. Dondero is the sole managing member of its general partner. Mr. Dondero has shared voting and dispositive power with respect to the shares of Series A Preferred Stock described above. Mr. Dondero disclaims beneficial ownership of all such shares except to the extent of his pecuniary interest therein.

| (2) | Includes 70,447.5 shares issuable upon vesting of restricted stock units within 60 days after February 25, 2025. Mr. McGraner has sole voting and dispositive power with respect to 295,394.25 shares of our common stock and shared voting and dispositive power with respect to 1,800 shares of our common stock held by a limited liability company in which Mr. McGraner owns an indirect minority interest. Mr. McGraner disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |

| (3) | Includes 15,170.25 shares issuable upon vesting of restricted stock units within 60 days after February 25, 2025. Mr. Mitts has sole voting and dispositive power with respect to 96,139.03 shares of our common stock, 7,748.53 of which are held by a 401(k) plan. Mr. Mitts has shared voting and dispositive power with respect to 95 shares of our common stock, which he may be deemed to own through his child. As of February 25, 2025, 40,876 shares held by Mr. Mitts are pledged as collateral to JP Morgan Chase & Co. |
| (4) | Includes 4,530 shares issuable upon vesting of restricted stock units within 60 days after February 25, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                      |
| (5) | Includes 2,265 shares issuable upon vesting of restricted stock units within 60 days after February 25, 2025.                                                                                                                                                                                                                                                                                                                                                                                                                      |

| (6) | In computing the aggregate number of shares beneficially owned and the aggregate percentage ownership by all directors and executive officers as a group, 1,800 shares which may be deemed to be beneficially owned by Mr. Dondero and Mr. McGraner, in each case have not been counted more than once. |

<div align='center'>38

AUDIT COMMITTEE REPORT